News & Updates

New drug applications approved by US FDA as of 16-28 February 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

For older adults, the efficacy of influenza vaccination is associated with vaccine-circulating strain matching, as reported in a study. If the strains are all matched, the vaccine can reduce the risk of hospitalization for community-acquired pneumonia by up to 28 percent.

Ivermectin did not prevent progression to severe COVID-19 in high-risk patients with mild-to-moderate COVID-19, according to a nationwide study.

The BNT162b2 mRNA vaccine proves to be highly effective against COVID-19 hospitalization and critical illness in adolescents aged 12 to 18 years, including those with pre-existing comorbidities, according to real-world data from the Overcoming COVID-19 surveillance network sponsored by the US CDC.